Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion.
作者信息
Rodriguez Carolyn I, Levinson Amanda, Zwerling Jordana, Vermes Donna, Simpson Helen Blair
出版信息
J Clin Psychiatry. 2016 May;77(5):688-9. doi: 10.4088/JCP.15l10318.
Abstract
摘要
相似文献
1
Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion.
J Clin Psychiatry. 2016 May;77(5):688-9. doi: 10.4088/JCP.15l10318.
2
Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
Psychopharmacol Bull. 2009;42(1):81-93.
3
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Trials. 2016 Mar 17;17(1):141. doi: 10.1186/s13063-016-1266-8.
4
Memantine reduces stealing behavior and impulsivity in kleptomania: a pilot study.
Int Clin Psychopharmacol. 2013 Mar;28(2):106-11. doi: 10.1097/YIC.0b013e32835c8c8c.
5
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial.
Neuropsychopharmacology. 2001 May;24(5):590-3. doi: 10.1016/S0893-133X(00)00194-9.
6
Ketamine followed by memantine for the treatment of major depression.
Aust N Z J Psychiatry. 2008 Feb;42(2):170. doi: 10.1080/00048670701787628.
7
A pilot double-blind treatment trial of memantine for alcohol dependence.
Alcohol Clin Exp Res. 2007 May;31(5):775-82. doi: 10.1111/j.1530-0277.2007.00360.x. Epub 2007 Mar 22.
8
Open-label pilot study of memantine in the treatment of compulsive buying.
Ann Clin Psychiatry. 2012 May;24(2):119-26.
9
Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
Curr Opin Anaesthesiol. 2009 Oct;22(5):618-22. doi: 10.1097/ACO.0b013e32832e7af6.
10
Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder.
J Clin Psychiatry. 2011 Apr;72(4):567-9. doi: 10.4088/JCP.10l06653.
引用本文的文献
1
Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review.
Cureus. 2023 Apr 19;15(4):e37833. doi: 10.7759/cureus.37833. eCollection 2023 Apr.
2
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.
Brain Sci. 2021 Jun 27;11(7):856. doi: 10.3390/brainsci11070856.
3
Pharmacotherapeutic Strategies and New Targets in OCD.
Curr Top Behav Neurosci. 2021;49:331-384. doi: 10.1007/7854_2020_204.
4
Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.
J Exp Pharmacol. 2021 Jan 5;12:695-706. doi: 10.2147/JEP.S255375. eCollection 2020.
5
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders.
Int Clin Psychopharmacol. 2020 Jul;35(4):173-193. doi: 10.1097/YIC.0000000000000314.
6
Obsessive-compulsive disorder.
Nat Rev Dis Primers. 2019 Aug 1;5(1):52. doi: 10.1038/s41572-019-0102-3.
7
Challenges in Testing Intranasal Ketamine in Obsessive-Compulsive Disorder.
J Clin Psychiatry. 2017 Apr;78(4):466-467. doi: 10.4088/JCP.16cr11234.
8
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.
Curr Neuropharmacol. 2017;15(7):977-995. doi: 10.2174/1570159X15666170320104237.
本文引用的文献
1
An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder.
Ind Psychiatry J. 2013 Jul;22(2):149-52. doi: 10.4103/0972-6748.132930.
2
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.
Neuropsychopharmacology. 2013 Nov;38(12):2475-83. doi: 10.1038/npp.2013.150. Epub 2013 Jun 19.
3
In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).
Psychopharmacology (Berl). 2013 Aug;228(4):633-40. doi: 10.1007/s00213-013-3067-z. Epub 2013 Mar 23.
4
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.
J Psychiatr Res. 2013 Feb;47(2):175-80. doi: 10.1016/j.jpsychires.2012.09.015. Epub 2012 Oct 9.
5
A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.
J Clin Psychopharmacol. 2010 Feb;30(1):34-9. doi: 10.1097/JCP.0b013e3181c856de.
6
Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
Psychopharmacol Bull. 2009;42(1):81-93.
7
Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
J Clin Psychopharmacol. 2009 Feb;29(1):51-5. doi: 10.1097/JCP.0b013e318192e9a4.
8
Practice guideline for the treatment of patients with obsessive-compulsive disorder.
Am J Psychiatry. 2007 Jul;164(7 Suppl):5-53.
9
Memantine augmentation for refractory obsessive-compulsive disorder.
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1173-5. doi: 10.1016/j.pnpbp.2006.04.013. Epub 2006 May 30.
10
Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.
J Clin Psychiatry. 2005 Dec;66(12):1549-57. doi: 10.4088/jcp.v66n1209.
Zotero 插件